Robert J. Chorvat

1.5k total citations
38 papers, 1.1k citations indexed

About

Robert J. Chorvat is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Robert J. Chorvat has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 14 papers in Molecular Biology and 11 papers in Pharmacology. Recurrent topics in Robert J. Chorvat's work include Synthesis and Reactivity of Heterocycles (6 papers), Neuroscience and Neuropharmacology Research (5 papers) and Cannabis and Cannabinoid Research (5 papers). Robert J. Chorvat is often cited by papers focused on Synthesis and Reactivity of Heterocycles (6 papers), Neuroscience and Neuropharmacology Research (5 papers) and Cannabis and Cannabinoid Research (5 papers). Robert J. Chorvat collaborates with scholars based in United States and China. Robert J. Chorvat's co-authors include Sheldon E. Cremer, John F. McElroy, Robert Zaczek, Raphael Pappo, George Kunos, Reşat Çınar, Tony Jourdan, Robert B. Innis, Kenner C. Rice and Grzegorz Godlewski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cell Metabolism and Journal of Medicinal Chemistry.

In The Last Decade

Robert J. Chorvat

36 papers receiving 1.0k citations

Peers

Robert J. Chorvat
Gilbert Lavielle France
Philip A. Carpino United States
J. Guy Breitenbucher United States
Laura Rauser United States
Elena Poggesi Italy
Lawrence S. Melvin United States
Graeme Semple United States
Don N. Harris United States
J. Silvestre Spain
Carol S. Surowy United States
Gilbert Lavielle France
Robert J. Chorvat
Citations per year, relative to Robert J. Chorvat Robert J. Chorvat (= 1×) peers Gilbert Lavielle

Countries citing papers authored by Robert J. Chorvat

Since Specialization
Citations

This map shows the geographic impact of Robert J. Chorvat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Chorvat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Chorvat more than expected).

Fields of papers citing papers by Robert J. Chorvat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Chorvat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Chorvat. The network helps show where Robert J. Chorvat may publish in the future.

Co-authorship network of co-authors of Robert J. Chorvat

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Chorvat. A scholar is included among the top collaborators of Robert J. Chorvat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Chorvat. Robert J. Chorvat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kale, Vijay P., Seth Gibbs, John Taylor, et al.. (2019). Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis. Regulatory Toxicology and Pharmacology. 109. 104483–104483. 21 indexed citations
2.
Chorvat, Robert J.. (2013). Peripherally restricted CB1 receptor blockers. Bioorganic & Medicinal Chemistry Letters. 23(17). 4751–4760. 81 indexed citations
3.
Tam, Joseph, Reşat Çınar, Jie Liu, et al.. (2012). Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance. Cell Metabolism. 16(2). 167–179. 296 indexed citations
4.
Chorvat, Robert J., et al.. (2012). JD-5006 and JD-5037: Peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities. Bioorganic & Medicinal Chemistry Letters. 22(19). 6173–6180. 76 indexed citations
5.
Beck, James P., et al.. (1999). Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(8). 1185–1188. 24 indexed citations
6.
Hodge, C. Nicholas, Paul E. Aldrich, Zelda R. Wasserman, et al.. (1999). Corticotropin-Releasing Hormone Receptor Antagonists:  Framework Design and Synthesis Guided by Ligand Conformational Studies. Journal of Medicinal Chemistry. 42(5). 819–832. 60 indexed citations
7.
Zaczek, Robert, Robert J. Chorvat, J Saye, et al.. (1998). Two New Potent Neurotransmitter Release Enhancers, 10,10-Bis(4-Pyridinylmethyl)-9(10H)-Anthracenone and 10,10-Bis(2-Fluoro-4-Pyridinylmethyl)-9(10H)-Anthracenone: Comparison to Linopirdine. Journal of Pharmacology and Experimental Therapeutics. 285(2). 724–730. 115 indexed citations
8.
Chorvat, Robert J., Robert Zaczek, & Barry S. Brown. (1998). Ion channel modulators that enhance acetylcholine release: potential therapies for Alzheimer’s disease. Expert Opinion on Investigational Drugs. 7(4). 499–518. 10 indexed citations
9.
Earl, Richard A., Robert Zaczek, Christopher A. Teleha, et al.. (1998). 2-Fluoro-4-pyridinylmethyl Analogues of Linopirdine as Orally Active Acetylcholine Release-Enhancing Agents with Good Efficacy and Duration of Action. Journal of Medicinal Chemistry. 41(23). 4615–4622. 25 indexed citations
10.
Zaczek, Robert, Robert J. Chorvat, & Barry S. Brown. (1997). Linopirdine: Pharmacology of a Neurotransmitter Release Enhancer. CNS Drug Reviews. 3(2). 103–119. 8 indexed citations
11.
Chorvat, Robert J., Lawrence A. Black, Vasant Ranade, et al.. (1993). Mono- and bis(aminomethyl)phenylacetic acid esters as short-acting antiarrhythmic agents. 2. Journal of Medicinal Chemistry. 36(17). 2494–2498. 5 indexed citations
12.
Desai, B.N., et al.. (1988). Synthesis and structure-activity relationships of a new series of antiarrhythmic agents: monobasic derivatives of disobutamide. Journal of Medicinal Chemistry. 31(11). 2158–2164. 8 indexed citations
13.
Chorvat, Robert J.. (1987). New Cardiovascular Drugs 1986. Journal of Pharmaceutical Sciences. 76(5). 420–420. 40 indexed citations
14.
Chorvat, Robert J. & B.N. Desai. (1980). Synthesis of 3,9‐dihydro‐3,9‐dioxo‐2H‐indeno[2,1‐c] pyridine‐4‐carbonitriles. Journal of Heterocyclic Chemistry. 17(6). 1313–1315. 3 indexed citations
15.
Chorvat, Robert J. & B.N. Desai. (1980). ChemInform Abstract: FACILE SYNTHESIS OF 3β‐HYDROXY‐5α‐CHOLEST‐8(14)‐EN‐15‐ONE 3‐ACETATE. Chemischer Informationsdienst. 11(19). 1 indexed citations
16.
Chorvat, Robert J. & B.N. Desai. (1979). Facile synthesis of 3.beta.-hydroxy-5.alpha.-cholest-8(14)-en-15-one 3-acetate. The Journal of Organic Chemistry. 44(22). 3974–3976. 16 indexed citations
17.
Chorvat, Robert J.. (1978). A facile synthesis of (3-methoxyisoquinol-7-yl)acetic acids. The Journal of Organic Chemistry. 43(19). 3778–3780. 2 indexed citations
18.
Goldstein, Joseph L., et al.. (1978). Inhibition of cholesteryl ester formation in human fibroblasts by an analogue of 7-ketocholesterol and by progesterone. Proceedings of the National Academy of Sciences. 75(4). 1877–1881. 65 indexed citations
19.
Chorvat, Robert J., et al.. (1975). Novel rearrangement of 6β,19-oxido-2,17-dihydroxyandrosta-1,4-dien-3-one. Tetrahedron. 31(11-12). 1353–1358. 2 indexed citations
20.
Cremer, Sheldon E., et al.. (1968). Pyramidal inversion in substituted phosphetanes. Tetrahedron Letters. 9(55). 5799–5802. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gilbert Lavielle Breakdown of academic impact, for papers by Philip A. Carpino Breakdown of academic impact, for papers by J. Guy Breitenbucher Breakdown of academic impact, for papers by Laura Rauser Breakdown of academic impact, for papers by Elena Poggesi Breakdown of academic impact, for papers by Lawrence S. Melvin Breakdown of academic impact, for papers by Graeme Semple Breakdown of academic impact, for papers by Don N. Harris Breakdown of academic impact, for papers by J. Silvestre Breakdown of academic impact, for papers by Carol S. Surowy
Rankless by CCL
2026